Among these, PKM2 is overexpressed in cancer cells [18]; furthermore, the PKM2 monomer can translocate into the nucleus where it behaves as a histone kinase and upregulates the expression of c-Myc and cyclin D1 [19,20]. This evidence concerns the gene MYC and cancer.